Metformin is associated with a reduction in the number of COVID-19 cases

Published Date: 08 Mar 2023

The latest data on metformin in COVID show benefits in the disease.

Read Full News

Latest News

Dolutegravir Shows Continued Success in Youth With HIV

Dolutegravir reduces viral load in adolescents and children in low- to middle-income nations.

US CDC Deploys Staff to Curb South Carolina's Measles Outbreak

(Refiles to remove extraneous word years from first paragraph)

After FDA Declined Review, EMA Backs 1st Flu-COVID mRNA Vax

The Moderna vaccine will likely be available in Europe long before the US.

Peak Anti-HBs Level May Predict Protection in HIV Infection

Peak anti-hepatitis B surface antibody levels predicted increased viral protection in HIV, a French study shows.

Doravirine Plus Islatravir Matches Standard HIV Therapy

In patients with HIV‑1 infection and virologic suppression, switching to an investigational regimen of doravirine plus islatravir shows efficacy and safety similar to standard ART regimens.

European Guidance Advances Cardiovascular Risk Assessment

The 2025 update integrates new risk estimation tools and shifts acute coronary syndrome management toward earlier intensive lipid-lowering therapy.

Todays Updates

Have the Harms of Lung Cancer Screening Been Exaggerated?

Three medical societies claim recent studies have overestimated the potential harms from lung cancer screening and may be deterring patients. Not everyone agrees.

Pretreatment Liver Tests Often Overlooked in CDK4/6 Therapy

Despite FDA package insert recommendations, most patients with breast cancer who are prescribed CDK4/6 inhibitors do not receive liver function tests before starting treatment.

Alternative Medicine for Breast Cancer: Study Raises Concern

Patients who receive both standard medical treatment and complementary and alternative therapies have higher mortality — possibly due to reduced use of endocrine therapy and radiation.

Todays Updates

Have the Harms of Lung Cancer Screening Been Exaggerated?

Three medical societies claim recent studies have overestimated the potential harms from lung cancer screening and may be deterring patients. Not everyone agrees.

Pretreatment Liver Tests Often Overlooked in CDK4/6 Therapy

Despite FDA package insert recommendations, most patients with breast cancer who are prescribed CDK4/6 inhibitors do not receive liver function tests before starting treatment.

Alternative Medicine for Breast Cancer: Study Raises Concern

Patients who receive both standard medical treatment and complementary and alternative therapies have higher mortality — possibly due to reduced use of endocrine therapy and radiation.

Latest News

Dolutegravir reduces viral load in adolescents and children in low- to middle-income nations.

(Refiles to remove extraneous word years from first paragraph)

The Moderna vaccine will likely be available in Europe long before the US.

Peak anti-hepatitis B surface antibody levels predicted increased viral protection in HIV, a French study shows.

In patients with HIV‑1 infection and virologic suppression, switching to an investigational regimen of doravirine plus islatravir shows efficacy and safety similar to standard ART regimens.

The 2025 update integrates new risk estimation tools and shifts acute coronary syndrome management toward earlier intensive lipid-lowering therapy.

News All Time

CROI 2026

Read clinically focused news coverage of key developments from CROI 2026.

Response to RSV Varies With Age

Tissue modeling outlines how respiratory syncytial virus promotes different disease outcomes in children and adults.

US CDC Vaccine Panel to Meet in March After February Session Scrapped

The U.S. Centers for Disease Control and Prevention's vaccine advisory committee is set to meet on March ⁠18 to 19, an update on the agency's website showed on Tuesday,...

Zimbabwe Ends $367 Million Health Funding Talks With US

Zimbabwe has pulled out of talks on a $367 million bilateral health agreement with the US due to concerns over sharing sensitive health data in return for financial support.

Long-Acting HIV Drug Switch Shows No Major Metabolic Impact

In patients with HIV infection, a switch to long acting cabotegravir plus rilpivirine shows no clinically meaningful changes in body composition or adverse metabolic effects over 48 weeks.

Mobile Telemedicine Boosts Rural Access to HCV Treatment

Among rural people with chronic HCV infection and a history of injection drug use, a mobile telemedicine-based intervention vs enhanced usual care improves treatment initiation and cure rates.

RSV Vaccine in Multidose Vial Matches Single-Dose Vial

In healthy, nonpregnant women, the multidose vial of RSVpreF vaccine produces immune responses and safety outcomes comparable to the single-dose vial, a trial finds.

US FDA Reverses Course, Will Review Moderna's Flu Vaccine Application

Moderna said on Wednesday the U.S. Food and Drug Administration changed course and will review an amended application for its new flu vaccine, a week after rejecting the...

AAP Finds No New Evidence Against Hep B Vaccine Birth Dose

AAP publishes review of safety and efficacy of hepatitis B vaccination birth dose.

Healthy Life Expectancy Declines Again

Years spent in good health have dropped to their lowest level since comparable data were first collected in 2011 to 2013, with stark regional gaps across the UK.

Long-Acting HIV Therapy May Be Safe After HBV Exposure

Switching to a long-acting cabotegravir/rilpivirine antiretroviral regimen may be safe for patients with HIV who have prior hepatitis B virus exposure, a real-world study shows.

Next-Day HIV Test Result Show Mixed Effects on Seeking Care

Next-day HIV viral load test results do not improve overall linkage to care when added to standard testing but are tied to faster linkage to antiretroviral therapy among people with HIV infection.

ED Screening Uncovers Elevated Risk for Cervical Cancer

Emergency department-based cervical cancer interventions identify precancerous lesions and high-risk human papillomavirus at rates higher than the national average, a study shows.

Cancer Screening Gaps Leave People With HIV at Elevated Risk

International guidelines recommend anal and liver surveillance for people with HIV, but Brazil lacks a national protocol; clinicians should integrate screening and vaccination.

Pritelivir Shows Promise for HSV

The new oral therapy demonstrates superior lesion healing for complex patients who have few current treatment options.

STI Prevention With Doxycycline Raises Resistance Fears

Public health authorities warn clinicians to weigh risks and enroll patients in supervised programs: routine testing, partner management, and resistance surveillance are essential.

Recommended News For You

Study opens up possibility of bespoke prostate cancer treatment

In a clinical trial, "3D mammography" nearly reduces the incidence of breast cancer between two screening exams.

'Cell-in-cell' mechanism explains how blood cancer uses bone marrow to evade treatment

EGFR Inhibitors for Lung Cancer Tied to Increased Keratitis Risk.

Mammo Responsibility Increases Screening; Opioids for Pain Related to Cancer? Ignored CRC Signs.

Geriatric Assessment, QoL Correlate With OS in Older Patients with Pancreatic Cancer

DNA origami offers more accurate imaging in the fight against pancreatic cancer

Recommended Articles For You

Fresh Frozen Plasma: Its Role in Treating Trauma and Bleeding Disorders 

Unlocking the Mystery of Hemoglobin C Trait: A Closer Look at a Rare Blood Disorder 

Unlocking the Mysteries of the Axillary Vein: Exploring its Role in Human Anatomy 

Beyond the Blood: Expanding CAR T-Cell Therapy to Solid Tumors- A New Era of Precision Oncology 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Early palliative care billing up from 2010 to 2019 for advanced cancer

2.

Kekoa Taparra, a native Hawaiian physician-scientist, is becoming well-known.

3.

FDA Approves Hemophilia B Second Gene Therapy.

4.

Colorectal Cancer Screening Uptake Tripled in 45-49 Age Group

5.

The self-sacrificing nature of breast cancer cells has been identified as a possible reason for relapse.

1.

Obesity is a major risk factor for cancer

2.

AI in Genomics: Decoding the Human Genome for Cancer Treatment

3.

The Journey Beyond Treatment: Empowering Cancer Survivorship with Technology and Artificial Intelligence

4.

Uncovering the Role of Pap Smear in Oncology: A New Frontier in Cancer Detection

5.

What Is Degos Disease? A Comprehensive Overview Of Symptoms, Diagnosis, and Treatment

1.

International Lung Cancer Congress®

2.

Future NRG Oncology Meeting

3.

Genito-Urinary Oncology Summit 2026

4.

ISMB 2026 (Intelligent Systems for Molecular Biology)

5.

Annual International Congress on the Future of Breast Cancer East

1.

Updates on the First Line Management of ALK+ NSCLC

2.

Treatment Sequencing Strategies in ALK + NSCLC Patients with CNS Diseases - Part II

3.

Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part VIII

4.

A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part VII

5.

Understanding the Multifaceted Advantages of CDK4/6 Inhibitors in HR+/HER2- PALOMA 2 Study.

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot